AstraZeneca has recently launched an initiative, making it easier for researchers to access their compounds and technologies and to collaborate with them.
The new open innovation website, developed by my AstraZeneca IMED biotech unit, will provide external researchers with a user-friendly gateway to the wide range of Open Innovation programs they offer.
